Red clover has a long history as a European folk medicine plant, and later became adopted into North American herbal traditions, including use by the Cherokee. It gained particular prominence in 19th-century Western herbalism as a general "blood purifier" and women's health remedy, a use that has narrowed considerably in modern research toward one specific application: menopausal symptom relief.
Red clover's modern reputation rests almost entirely on its isoflavone content — plant compounds structurally similar to estrogen — positioning it as a phytoestrogen alternative to hormone replacement therapy.
Red clover has a genuinely mixed evidence picture, with meta-analyses leaning modestly positive while individual trials remain notably inconsistent. A recent GRADE-assessed meta-analysis of 9 randomized controlled trials found a statistically significant, small-to-moderate reduction in hot flash frequency compared to placebo. An earlier meta-analysis of 8 trials similarly found a significant reduction, with the strongest effects at doses of 80mg or more of isoflavones daily over at least 12 weeks.
The genuine complication: individual large trials disagree meaningfully. The well-known Isoflavone Clover Extract (ICE) study, involving 252 women, found no significant difference between red clover and placebo. A 2014 review described the overall evidence as "insufficient" and "inconclusive," and separately noted that over half of published red clover trials were at least partially funded by product manufacturers. Europe's food safety authority has found no adequate evidence supporting isoflavone claims for menopausal symptoms. "Limited-Moderate" is the honest, balanced rating.
Flowers dried and steeped as tea; modern research uses standardized isoflavone extracts (commonly branded as Promensil or similar).